Advagene Biopharma Co., Ltd. (6709.TWO)
TWD 18.45
(2.5%)
TWD 18.45
(2.5%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 7.97 Million TWD | -12.16% |
| 2022 | 9.07 Million TWD | -16.26% |
| 2021 | 10.83 Million TWD | -35.99% |
| 2020 | 16.93 Million TWD | 115.64% |
| 2019 | 7.85 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 17.94 Million TWD | 125.14% |
| 2024 Q2 | 17.94 Million TWD | 0.0% |
| 2023 FY | 7.97 Million TWD | -12.16% |
| 2023 Q2 | 8.77 Million TWD | 0.0% |
| 2023 Q1 | 8.77 Million TWD | -3.36% |
| 2023 Q3 | 7.97 Million TWD | -9.11% |
| 2023 Q4 | 7.97 Million TWD | 0.0% |
| 2022 Q3 | 9.07 Million TWD | 0.0% |
| 2022 Q4 | 9.07 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 98.634% |
| Level Biotechnology Inc. | 273.2 Million TWD | 97.082% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 94.216% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 95.963% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 99.4% |
| GlycoNex Incorporation | 276.39 Million TWD | 97.116% |
| VBI | 21.25 Million TWD | 62.486% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 97.459% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 98.451% |
| Visgeneer Inc. | 185.6 Million TWD | 95.705% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 99.398% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 98.912% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 93.349% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 99.645% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -20.459% |
| Enimmune corporation | 173.46 Million TWD | 95.404% |
| TaiRx, Inc. | 60.62 Million TWD | 86.85% |
| CHO Pharma, Inc. | 110.83 Million TWD | 92.807% |
| EirGenix Inc. | 1.14 Billion TWD | 99.304% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 92.881% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 98.444% |
| Lin BioScience, Inc. | 167.73 Million TWD | 95.247% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | 91.493% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | 87.353% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 93.609% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 95.05% |
| RBC Bioscience Corporation | 513.08 Million TWD | 98.446% |
| BiOptic Inc. | 170.56 Million TWD | 95.326% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | 81.09% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | 65.719% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | 70.268% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 99.182% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -13.983% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | 62.442% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 97.836% |
| Neith Corporation | 17.43 Million TWD | 54.271% |
| NaviFUS Corp. | 53.4 Million TWD | 85.071% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 98.344% |
| Sinew Pharma Inc. | 39.71 Million TWD | 79.926% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | 86.264% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 97.813% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 96.499% |
| AP Biosciences Inc | 106.65 Million TWD | 92.525% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 99.774% |
| 3D Global Biotech Inc. | 30.68 Million TWD | 74.016% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 95.932% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 99.483% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 99.08% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | 14.058% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | 85.717% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 96.578% |
| TCI GENE Inc. | 155.54 Million TWD | 94.875% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | 68.747% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | 82.735% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 97.573% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | 87.714% |
| PharmaEngine, Inc. | 91 Million TWD | 91.24% |
| Savior Lifetec Corporation | 457.95 Million TWD | 98.259% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 92.814% |
| OBI Pharma, Inc. | 650.44 Million TWD | 98.774% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 97.96% |
| Acepodia, Inc. | 384.47 Million TWD | 97.927% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | 90.682% |